chrysamine G derivatives (University of Pittsburgh/University of Pittsburgh-Office of Technology Management)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namechrysamine G derivatives (University of Pittsburgh/University of Pittsburgh-Office of Technology Management)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A